Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281619 · ClinicalTrials.gov registry record
PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 29
- Enrollment target
NCT00281619 is a clinical trial that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 29 participants.
The verdict
NCT00281619 has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how fast children, who have had a recent kidney transplant, absorb, breakdown and eliminate mycophenolic acid (CellCept) following their prescribed dose. The results may lead to better dosing based on individual needs.
Interventions
- BEHAVIORAL Dietary Monitoring
- PROCEDURE Blood Sampling
- DRUG CellCept (mycophenolate mofetil)
- BEHAVIORAL Drug Diary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2006-01 |
| Est. Completion | 2010-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00281619
The ClinicalTrials.gov registry entry for NCT00281619 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Dietary Monitoring is the first listed.
NCT00281619 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00281619 about?
NCT00281619 is a clinical study titled "PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients". The purpose of this study is to determine how fast children, who have had a recent kidney transplant, absorb, breakdown and eliminate mycophenolic acid (CellCept) following their prescribed dose. The results may lead to better dosing based on individual needs.
What is the current status of trial NCT00281619?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2006-01. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00281619?
The interventions under investigation include: Dietary Monitoring (BEHAVIORAL), Blood Sampling (PROCEDURE), CellCept (mycophenolate mofetil) (DRUG), Drug Diary (BEHAVIORAL).
Who is sponsoring clinical trial NCT00281619?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.